Byannli (previously Paliperidone Janssen-Cilag International) European Union - English - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidone palmitate - schizophrenia - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.1).

Percutaneous medicine administration kit, medicated, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

percutaneous medicine administration kit, medicated, single-use

janssen-cilag pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - a kit for the intramuscular administration of the medicine risperdal consta. kit includes the medicine risperdal consta; a prefilled syringe containing a dilutent; one needle-free vial access device; two needles with needle protection devices (21g for deltoid administration and a 20g for gluteal administration).

Prezista New Zealand - English - Medsafe (Medicines Safety Authority)

prezista

janssen-cilag (new zealand) ltd - darunavir ethanolate 325.23mg equivalent to darunavir 300 mg - film coated tablet - 300 mg - active: darunavir ethanolate 325.23mg equivalent to darunavir 300 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 300mg;   - film coated tablet - 300 mg - active: topiramate 300mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry as opadry red ys-1-1759-g sodium starch glycolate starch

Topamax New Zealand - English - Medsafe (Medicines Safety Authority)

topamax

janssen-cilag (new zealand) ltd - topiramate 400mg;   - film coated tablet - 400 mg - active: topiramate 400mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g as opadry white ys-1-7706-g sodium starch glycolate starch

Velcade New Zealand - English - Medsafe (Medicines Safety Authority)

velcade

janssen-cilag (new zealand) ltd - bortezomib 3.5mg (as a bortezomib mannitol ester that is formed during fp manufacture.) - powder for injection - 3.5 mg - active: bortezomib 3.5mg (as a bortezomib mannitol ester that is formed during fp manufacture.) excipient: mannitol - velcade in combination with melphalan and prednisone, is indicated for the treatment of patients with previously untreated multiple myeloma, who are not suitable for high dose chemotherapy. velcade as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. velcade is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.

Prezista New Zealand - English - Medsafe (Medicines Safety Authority)

prezista

janssen-cilag (new zealand) ltd - darunavir ethanolate 867.28mg equivalent to darunavir 800 mg - film coated tablet - 800 mg - active: darunavir ethanolate 867.28mg equivalent to darunavir 800 mg excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate opadry red 85f150004 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.